Tenet Healthcare
THC
259.83
+1.36
+0.53%
Tenet Healthcare
US · THC
#905 by market cap
Listed 1970
259.83
+1.36
+0.53%
Live - 5344 symbols - heartbeat 377s ago
· 2026-10-08 07:39
Pre-market
259.83
0.00%
After-hours
259.45
-0.15%
- Market cap
- 20.92B
- P/E (TTM)i
- 10.04
- P/Bi
- 4.49
- EPSi
- 15.49
- Div yieldi
- 0.00%
- 52W posi
- 81%
Reader sentiment
Are you bullish or bearish on THC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 4 in the most recent period (2026/Q3).
- Total institutional ownership fell 1.2 percentage points.
Institutional ownership
- Held by institutions
- 99.81% -1.18pp
- Institutions
- 783 -4
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund79.06%
Hedge Fund11.79%
Public Company3.09%
Private Company1.73%
Sovereign Wealth Fund1.52%
Government Pension Fund1.49%
Individual/Insider0.89%
Family Office/Trust0.56%
Insurance Company0.22%
Top holders as of 2026-06-30
T. Rowe Price Group, Inc.
10.87% · 8.75M sh
BlackRock
10.04% · 8.08M sh
Vanguard Capital Management, LLC
5.51% · 4.44M sh
Boston Partners Global Investors, Inc.
5.51% · 4.43M sh
Vanguard Portfolio Management, LLC
5.26% · 4.24M sh
FMR
4.95% · 3.99M sh
State Street Global Advisors
3.42% · 2.75M sh
Glenview Capital Management, LLC
2.78% · 2.24M sh
Geode Capital Management, LLC
2.34% · 1.88M sh
Citadel Advisors LLC
2.19% · 1.77M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 22 buys · 27 sells
| Name | Role | Stake |
|---|---|---|
| Saumya Sutaria | Chairperson & CEO | 0.54% |
| Michael Maloney | Officer | 0.13% |
| Nadja West | Independent Director | 0.03% |
| James Bierman | Independent Director | 0.03% |
| Tammy Romo | Independent Director | 0.03% |
| Sun Park | Executive Vice President | 0.02% |
| Paola Arbour | Executive Vice President | 0.02% |
| Richard Mark | Independent Director | 0.02% |
| Cecil Haney | Independent Director | 0.02% |
| Meghan FitzGerald | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-13 | Joseph Kerrey | Lead Independent Director | Open Market Disposition | -12,010 | $263.04–264.62 |
| 2026-09-09 | Richard Mark | Independent Director | Open Market Disposition | -10,000 | $263.42 |
| 2026-09-01 | Nadja West | Independent Director | Open Market Disposition | -1,152 | $258.80 |
| 2026-08-30 | Lisa Foo | Executive Vice President of Commercial Operations | Open Market Disposition | -24,000 | $266.32 |
| 2026-08-27 | Cecil Haney | Independent Director | Other Disposition | -150 | -- |
| 2026-08-24 | Saumya Sutaria | Chairperson & CEO | Open Market Disposition | -100,000 | $273.34–278.90 |
| 2026-08-24 | Saumya Sutaria | Chairperson & CEO | Intent to Sell (Form 144) | -50,000 | $274.02 |
| 2026-08-23 | Cecil Haney | Independent Director | Open Market Disposition | -1,300 | $278.03 |
| 2026-08-23 | Saumya Sutaria | Chairperson & CEO | Intent to Sell (Form 144) | -50,000 | $278.70 |
| 2026-08-06 | Tammy Romo | Independent Director | Open Market Disposition | -7,422 | $260.83–264.15 |
| 2026-08-06 | Tammy Romo | Independent Director | Intent to Sell (Form 144) | -2,500 | $260.83 |
| 2026-08-05 | Tammy Romo | Independent Director | Intent to Sell (Form 144) | -4,922 | $264.15 |
| 2026-08-04 | Roy Blunt | Director | Open Market Disposition | -600 | $262.68 |
| 2026-07-28 | Lisa Foo | Executive Vice President of Commercial Operations | Open Market Disposition | -10,000 | $258.03 |
| 2026-07-26 | James Bierman | Independent Director | Open Market Disposition | -5,000 | $244.96 |
| 2026-07-26 | Christopher Lynch | Independent Director | Open Market Disposition | -3,837 | $243.44 |
| 2026-07-26 | Paola Arbour | Executive Vice President | Open Market Disposition | -10,878 | $243.90 |
| 2026-05-27 | Joseph Kerrey | Lead Independent Director | Open Market Disposition | -5,638 | $173.12–177.52 |
| 2026-05-26 | James Bierman | Independent Director | Other Derivative Acquisition | +1,188 | -- |
| 2026-05-26 | Meghan FitzGerald | Independent Director | Other Derivative Acquisition | +1,188 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:39:15 · For reference only, not investment advice and not tailored to your situation.